Clover Health Investments Q2 Sales $513.63M Beat $490.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Clover Health Investments (NASDAQ:CLOV) reported Q2 sales of $513.63 million, beating the analyst consensus estimate of $490.82 million by 4.65 percent. However, this represents a 39.34 percent decrease compared to the same period last year.
August 08, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Clover Health's Q2 sales exceeded estimates but are significantly lower than last year's figures.
While Clover Health beat the Q2 sales estimates, the significant YoY decrease could be a concern for investors. This mixed result makes the short-term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100